About: FOLFIRI-Cetuximab Regimen

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: FOLFIRI-Cetuximab Regimen Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz:8890 associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	FOLFIRI-Cetuximab Regimen
rdfs:subClassOf	Chemotherapy Regimen Used to Treat Colorectal Carcinoma nodeID://b672453 nodeID://b672454 nodeID://b672455 nodeID://b672456 nodeID://b672457
Semantic_Type	Therapeutic or Preventive Procedure
Preferred_Name	FOLFIRI-Cetuximab Regimen
PDQ_Open_Trial_Search_ID	744911
PDQ_Closed_Trial_Search_ID	744911
FULL_SYN	FOLFIRI-Erbitux RegimenSYNCI Leucovorin-Fluorouracil-Irinotecan-Cetuximab RegimenSYNCI FOLFIRI-Cetuximab RegimenPTNCI
DEFINITION	A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS.NCI
code	C104152

Faceted Search & Find service v1.16.121 as of Mar 31 2025

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Mar 31 2025, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 14 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software